Author:
Dias Joana N. R.,André Ana S.,Aguiar Sandra I.,Gil Solange,Tavares Luís,Aires-da-Silva Frederico
Abstract
Graphical AbstractThe application of canine lymphoma as an animal model for immunotherapeutic approaches in comparative medicine provides an integrated drug discovery platform that maximize interdisciplinary cooperation and leverage commonalities across humans and dogs for the development of novel immunotherapies against non-Hodgkin lymphoma, benefiting both species.
Funder
Fundação para a Ciência e a Tecnologia
Reference154 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018
2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol.,2017
3. Global cancer incidence and mortality rates and trends—an update;Torre;Cancer Epidemiol Prev Biomark.,2016
4. Cancer immunotherapy: Harnessing the immune system to battle cancer;Yang;J Clin Invest.,2015
5. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape;Emens;Eur J Cancer.,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献